Monday, September 28, 2015

Postmastectomy Radiotherapy Should Not Be Routinely Recommended For Breast Cancer Patients With Microscopic Nodal Metastases And T1-2 Tumors, Study Suggests

Oncology Practice (9/27, Nelson) reports that research suggests that “postmastectomy radiotherapy should not be routinely recommended for breast cancer patients with microscopic nodal metastases (N1mic) and T1-2 tumors.” Investigators found that “in patients with T1-2, N1 disease who were treated with standard therapies, the study authors found that overall, there were low rates of locoregional failure.” The findings were presented at the 2015 Breast Cancer Symposium. 

Categories: 2015, September, News, Research and CareNumber of views: 8373


Theme picker